Clinical Research Directory
Browse clinical research sites, groups, and studies.
Preeclampsia Postpartum Antihypertensive Treatment
Sponsor: Medical College of Wisconsin
Summary
The goal of this study is to compare whether antihypertensive treatment in the postpartum period decreases postpartum hypertension and its associated maternal morbidity, including risk of readmission and healthcare utilization in comparison with no treatment. Women with preeclampsia diagnosed during the antepartum, intrapartum or postpartum period will be randomized to either initiate antihypertensive treatment or standard of care. We hypothesize that postpartum antihypertensive treatment of patients with preeclampsia will decrease risk of hospital readmission, healthcare utilization and the number of severe range blood pressures at postpartum follow-up visits.
Official title: Randomized Controlled Trial for Postpartum Antihypertensive Treatment of Women With Preeclampsia
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2020-07-17
Completion Date
2025-12-30
Last Updated
2025-10-23
Healthy Volunteers
No
Conditions
Interventions
Labetalol, Nifedipine
Antihypertensive treatment that is safe and well studied in peripartum women.
Locations (1)
Medical College of Wisconsin-Froedtert Hospital
Milwaukee, Wisconsin, United States